My bookmarksSign up free

95/571/EC: Council Decision of 18 December 1995 concerning the conclusion of an Agreement between the European Community and the Republic of Venezuela on precursors and chemical substances frequently used in the illicit manufacture of narcotic drugs or psychotropic substances

95/571/EC: Council Decision of 18 December 1995 concerning the conclusion of an Agreement between the European Community and the Republic of Venezuela on precursors and chemical substances frequently used in the illicit manufacture of narcotic drugs or psychotropic substances

Decision · 1 article

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

full

30.12.1995    EN Official Journal of the European Communities L 324/34 COUNCIL DECISION of 18 December 1995 concerning the conclusion of an Agreement between the European Community and the Republic of Venezuela on precursors and chemical substances frequently used in the illicit manufacture of narcotic drugs or psychotropic substances (95/571/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 113 thereof, in conjunction with the first sentence of Article 228 (2), and Article 228 (4) thereof, Having regard to the recommendation from the Commission, Whereas, on 25 September 1995, the Council authorized the Commission to negotiate, on behalf of the Community, agreements on the control of precursors and chemical substances with the Member States of the Organization of American States, and as a priority with the Member Countries of the Cartagena Agreement; whereas the Commission, on the basis of this authorization, completed negotiations with the Republic of Venezuela on 13 November 1995; Whereas it is appropriate that the Agreement between the European Community and the Republic of Venezuela on precursors and chemical substances frequently used in the illicit manufacture of narcotic drugs or psychotropic substances should be approved; Whereas it is appropriate that the Council authorize the Commission, in consultation with a special committee appointed by the Council, to approve modifications on behalf of the Community where the Agreement provides for them to be adopted by the Joint Follow-Up Group; whereas, such authorization must be limited to the modification of the Annexes of the Agreement in so far as it concerns substances already covered by Community legislation on precursors and chemical substances, HAS DECIDED AS FOLLOWS: Article 1 The Agreement between the European Community and the Republic of Venezuela on precursors and chemical substances frequently used in the illicit manufacture of narcotic drugs or psychotropic substances is approved on behalf of the Community. The text of the Agreement is attached to this Decision. Article 2 The President of the Council is hereby authorized to designate the person empowered to sign the Agreement. Article 3 The President of the Council shall, on behalf of the Community, deposit the instrument provided for in Article 12 of the Agreement  ( 1 ) . Article 4 1.   The Community shall be represented in the Joint Follow-Up Group provided for in Article 9 of the Agreement by the Commission, assisted by the representatives of the Member States. 2.   The Commission is authorized to approve, on behalf of the Community, modifications to the Annexes to the Agreement adopted by the Joint Follow-Up Group by the procedure laid down in Article 10 of the Agreement. The Commission shall be assisted in this task by a special committee designated by the Council and charged with establishing a common position. 3.   The authorization referred to in paragraph 2 shall be limited to those substances which are already covered by the relevant Community legislation on drugs precursors and chemical substances. Article 5 This Decision shall be published in the Official Journal of the European Communities . Done at Brussels, 18 December 1995. For the Council The President J. BORRELL FONTELLES ( 1 )   The date of entry into force of the Agreement will be published in the Official Journal of the European Communities by the General Secretariat of the Council.

Other acts of the same type
Commission Implementing Decision (EU) 2026/1111 of 22 May 2026 postponing the expiry date of the approval of disodium tetraborate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1112 of 22 May 2026 not renewing the approval of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1128 of 22 May 2026 postponing the expiry date of the approval of boric acid for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1129 of 22 May 2026 postponing the expiry date of the approval of IPBC for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCouncil Decision (CFSP) 2026/1152 of 22 May 2026 extending the mandate of the European Union Special Representative for the Middle East Peace Process and amending Decision (CFSP) 2025/976Council Decision (CFSP) 2026/1153 of 22 May 2026 on an assistance measure under the European Peace Facility to support the Albanian Armed ForcesCouncil Decision (CFSP) 2026/1157 of 22 May 2026 amending Decision (CFSP) 2023/1532 concerning restrictive measures in view of Iran’s military support to Russia’s war of aggression against Ukraine and to armed groups and entities in the Middle East and the Red Sea regionCommission Implementing Decision (EU) 2026/1162 of 21 May 2026 amending Implementing Decision (EU) 2021/1803 setting out the provisional amounts allocated to each Member State from the resources of the Brexit Adjustment Reserve and the minimum amount of support to local and regional coastal communities (notified under document C(2026) 1768)Commission Implementing Decision (EU) 2026/1089 of 20 May 2026 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1145 of 20 May 2026 amending the Annexes to Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (notified under document C(2026) 3474)Commission Implementing Decision (EU) 2026/1141 of 19 May 2026 on the request for registration, pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council, of the European citizens’ initiative entitled Rights for Nature: Empower Citizens to Represent and Protect EcosystemsCommission Implementing Decision (EU) 2026/1142 of 19 May 2026 on the request for registration, pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council, of the European citizens’ initiative entitled Reconnecting nature through the creation of European biodiversity corridors

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next